Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach. [electronic resource]
Producer: 20200114Description: 731-738 p. digitalISSN:- 1747-4132
- Adalimumab -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Biosimilar Pharmaceuticals -- administration & dosage
- Crohn Disease -- diagnosis
- Drug Costs
- Drug Monitoring -- economics
- Early Diagnosis
- Humans
- Inflammatory Bowel Diseases -- economics
- Patient Care Team
- Patient-Centered Care -- economics
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.